JB Vermorken

2.6k citations
11 papers · 325 indexed · h-index 6
Topics
Cancer Treatment and Pharmacology (3 papers)Drug Transport and Resistance Mechanisms (2 papers)Cancer Genomics and Diagnostics (2 papers)
Partner nations
NetherlandsBelgiumItaly

In The Last Decade

JB Vermorken

10 papers receiving 316 citations

Peers

JB Vermorken
Comparison fields: 5 of 53
  • Oncology 217
  • Pulmonary and Respiratory Medicine 104
  • Molecular Biology 103
  • Otorhinolaryngology 86
  • Surgery 50
Replace Amine Bensmaine with:
Amine Bensmaine United States
Yuzhi Lu China
Aaron E. Sosa Spain
Jie‐Hua He China
Hsiang‐Fong Kao Taiwan
Sulsal Haque United States
Floris M Wachters Netherlands
Hirofumi Satake Japan
Naomi Monden Japan
Trevor Feinstein United States
JB Vermorken relative to Amine Bensmaine United States Amine Bensmaine's profile →
Citations per field
00.5×
Amine Bensmaine · 1×
Citations per year

Countries citing papers authored by JB Vermorken

Since Specialization
Citations

This map shows the geographic impact of JB Vermorken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JB Vermorken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JB Vermorken more than expected).

Fields of papers citing papers by JB Vermorken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JB Vermorken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JB Vermorken. The network helps show where JB Vermorken may publish in the future.

Co-authorship network of co-authors of JB Vermorken

This figure shows the co-authorship network connecting the top 25 collaborators of JB Vermorken. A scholar is included among the top collaborators of JB Vermorken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JB Vermorken. JB Vermorken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 1
2 178
3 1
4
Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function.
46
5 4
6 9
7 0
8 7
9
Advanced ovarian cancer. Carboplatin versus cisplatin.
18
10 58
11 3

About JB Vermorken

JB Vermorken is a scholar working on Oncology, Reproductive Medicine and Pharmaceutical Science, having authored 11 papers that have together received 325 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Otorhinolaryngology (86 citations), Oncology (217 citations) and Pulmonary and Respiratory Medicine (104 citations). JB Vermorken has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Andrzej Kawecki, Ricard Mesı́a, Sylvie Rottey, Fernando Rivera, Lisa Licitra, Stephan Störkel, Christopher Stroh, Ricardo Hitt, Stefanie Senger and J. Erfán. Their work appears in journals such as Cancer Research, British Journal of Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026